These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3213607

  • 1. The effect of fluoride on bone histology in postmenopausal osteoporosis depends on adequate fluoride absorption and retention.
    Budden FH, Bayley TA, Harrison JE, Josse RG, Murray TM, Sturtridge WC, Kandel R, Vieth R, Strauss AL, Goodwin S.
    J Bone Miner Res; 1988 Apr; 3(2):127-32. PubMed ID: 3213607
    [Abstract] [Full Text] [Related]

  • 2. The relationship between fluoride effects on bone histology and on bone mass in patients with postmenopausal osteoporosis.
    Harrison JE, Bayley TA, Josse RG, Murray TM, Sturtridge W, Williams C, Goodwin S, Tam C, Fornasier V.
    Bone Miner; 1986 Sep; 1(4):321-33. PubMed ID: 3504712
    [Abstract] [Full Text] [Related]

  • 3. [Histological effects of the treatment of osteoporosis with the combination of sodium fluoride, vitamin D and calcium].
    Briançon D, Charhon S, Edouard C, Meunier PJ.
    Rev Rhum Mal Osteoartic; 1980 Dec; 47(12):693-8. PubMed ID: 7006045
    [Abstract] [Full Text] [Related]

  • 4. The long-term treatment of steroid osteoporosis with fluoride.
    Bayley TA, Muller C, Harrison J, Basualdo J, Sturtridge W, Josse R, Murray TM, Pritzker KP, Vieth R, Goodwin S.
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S157-61. PubMed ID: 2339626
    [Abstract] [Full Text] [Related]

  • 5. [Bone histology in postmenopausal osteoporosis--variations in cellular activity].
    Lozo P, Krpan D, Krvavica A, Vukelić Baturić T, Fistonić I, Kusec V.
    Acta Med Croatica; 2004 Mar; 58(1):5-11. PubMed ID: 15125387
    [Abstract] [Full Text] [Related]

  • 6. Fluoride treatment of postmenopausal osteoporosis: age, renal function, and other clinical factors in the osteogenic response.
    Murray TM, Harrison JE, Bayley TA, Josse RG, Sturtridge WC, Chow R, Budden F, Laurier L, Pritzker KP, Kandel R.
    J Bone Miner Res; 1990 Mar; 5 Suppl 1():S27-35. PubMed ID: 2339633
    [Abstract] [Full Text] [Related]

  • 7. The microscopic morphology of fluoride-induced bone.
    Vigorita VJ, Suda MK.
    Clin Orthop Relat Res; 1983 Mar; (177):274-82. PubMed ID: 6407795
    [Abstract] [Full Text] [Related]

  • 8. Safety of osteoporosis treatment with sodium fluoride, calcium phosphate and vitamin D.
    Hasling C, Nielsen HE, Melsen F, Mosekilde L.
    Miner Electrolyte Metab; 1987 Mar; 13(2):96-103. PubMed ID: 3696093
    [Abstract] [Full Text] [Related]

  • 9. The effect of exercise on bone mass of osteoporotic patients on fluoride treatment.
    Chow RK, Harrison JE, Sturtridge W, Josse R, Murray TM, Bayley A, Dornan J, Hammond T.
    Clin Invest Med; 1987 Mar; 10(2):59-63. PubMed ID: 3581547
    [Abstract] [Full Text] [Related]

  • 10. [Comparative effects of sodium fluoride and hormonal replacement therapy on bone metabolism in osteoporotic women with high fracture risk. Results of monitoring for 2 years].
    Pouillès JM, Trémollières F, Ribot C.
    Rev Rhum Mal Osteoartic; 1992 Feb; 59(2):103-13. PubMed ID: 1604221
    [Abstract] [Full Text] [Related]

  • 11. Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis.
    Orwoll ES, McClung MR, Oviatt SK, Recker RR, Weigel RM.
    J Bone Miner Res; 1989 Feb; 4(1):81-8. PubMed ID: 2718782
    [Abstract] [Full Text] [Related]

  • 12. [Loss of trabecular bone strength and bone quality after 5 years of fluoride therapy for osteoporosis].
    Søgaard CH, Mosekilde L, Richards A, Mosekilde L.
    Ugeskr Laeger; 1995 Apr 03; 157(14):2004-8. PubMed ID: 7740640
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Iliac bone biopsies at the time of periarticular stress fractures during fluoride therapy: comparison with pretreatment biopsies.
    Schnitzler CM, Mesquita JM, Gear KA, Robson HJ, Moodley GP, Smyth AE.
    J Bone Miner Res; 1990 Feb 03; 5(2):141-52. PubMed ID: 2316402
    [Abstract] [Full Text] [Related]

  • 17. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
    Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ, Meunier PJ.
    J Clin Invest; 1997 Sep 15; 100(6):1475-80. PubMed ID: 9294113
    [Abstract] [Full Text] [Related]

  • 18. [Osteoporosis therapy and thyroid function. Influence of 6 months of sodium fluoride treatment on thyroid function and bone density].
    Eichner R, Börner W, Henschler D, Köhler W, Moll E.
    Fortschr Med; 1981 Mar 12; 99(10):342-8. PubMed ID: 7216100
    [Abstract] [Full Text] [Related]

  • 19. [Effects of the combined raloxifene-sodium fluoride therapy on bone mass and bone turnover in women with postmenopausal osteoporosis].
    Celi M, Letizia C, Ragno A, Minisola S, D'Erasmo E, Mazzuoli GF.
    Minerva Med; 2002 Dec 12; 93(6):471-8. PubMed ID: 12515970
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.